Cytokine Signalling Forum
Sign in   Register
  • Home
  • Publications
  • Podcasts
  • Congresses
  • Educational Videos
  • Resources
  • CSF Live
  • Contact

Literature Highlights

Back to Publications To Literature Searches

Each month the CSF Steering Committee selects the latest published original articles on RA, PsA, and axSpA, focusing on those with data on therapeutic interventions and those that have clinical impact.

Literature review thumbnail: AxSpA Literature Highlights – October 2022
View Slides

AxSpA Literature Highlights – October 2022

Ixekizumab, Certolizumab Pegol, Bimekizumab

more…

Literature review thumbnail: RA Literature Highlights – October 2022
View Slides

RA Literature Highlights – October 2022

Baricitinib, Tofacitinib, JAK Inhibition, JAK Inhibitor Switching, Tofacitinib

more…

Literature review thumbnail: AxSpA Literature Highlights – September 2022
View Slides

AxSpA Literature Highlights – September 2022

Ixekizumab, COMBIO

more…

Literature review thumbnail: PsA Literature Highlights – September 2022
View Slides

PsA Literature Highlights – September 2022

Upadacitinib, Secukinumab, Guselkumab, Risankizumab, MCID

more…

Literature review thumbnail: RA Literature Highlights – September 2022
View Slides

RA Literature Highlights – September 2022

IL-6 Inhibition, Tofacitinib, JAK Inhibition, Upadacitinib, Sarilumab, Olokizumab, Baricitinib, Filgotinib

more…

Literature review thumbnail: AxSpA Literature Highlights – August 2022
View Slides

AxSpA Literature Highlights – August 2022

Upadacitinib, Bimekizumab, JAK Inhibition

more…

Literature review thumbnail: PsA Literature Highlights – August 2022
View Slides

PsA Literature Highlights – August 2022

Secukinumab, Bimekizumab, Risankizumab, CHOICE, SELECT-PsA-1, SELECT-PsA-2

more…

Literature review thumbnail: RA Literature Highlights – August 2022
View Slides

RA Literature Highlights – August 2022

bDMARD, tsDMARD, JAK Inhibition, KL130008, Filgotinib

more…

Literature review thumbnail: AxSpA Single Slide Summaries – July 2022
View Slides

AxSpA Single Slide Summaries – July 2022

Upadacitinib, Drug-free Remission, Secukinumab, SERENA

more…

Literature review thumbnail: PsA Single Slide Summaries - July
View Slides

PsA Single Slide Summaries - July

Bimekizumab, Guselkumab, Ixekizumab, Apremilast, Secukinumab, General Health Outcomes

more…

‹ 1 2 3 4 ›

Developed under the auspices of:

University of Glasgow

With sponsorship and unrestricted educational grants from:

Abbvie logo Galapagos logo
Lilly logo Pfizer logo

Follow us on:

Twitter LinkedIn Facebook Apple Podcasts

© 2014 - 2023 | Supported by CESAS Medical. Legal | Contact | Site Map

APEX Award Winning logo
Health Awards logo